
In this “Ask Me Anything” (AMA) episode, Peter dives deep into nicotine—a topic increasingly debated both scientifically and publicly. He clarifies the critical differences between nicotine and tobacco, highlighting why nicotine alone isn't...
Loading summary
Peter Attia
Foreign.
Nick
Hey everyone. Welcome to a Sneak Peek, Ask Me Anything or AMA episode of the Drive podcast. I'm your host, Peter Attia. At the end of this short episode, I'll explain how you can access the AMA episodes in full, along with a ton of other membership benefits we've created. Or you can learn more now by going to Peteratti md.com forward slash, subscribe. So, without further delay, here's today's sneak peek of the Ask Me Anything episode.
Unknown
Welcome to ask Me Anything AMA episode number 70. For today's AMA, we're discussing a topic that has been gaining significant attention in both the scientific community and among the public, and that is nicotine. This is a topic that we get a lot of questions about, not only from our audience, but also from my patients. In this episode, we discuss the distinction between nicotine and tobacco, understanding why nicotine itself is not the primary driver of the major health risks associated with smoking. We discuss the risks of nicotine use, including addiction, sleep disturbances, cardiovascular effects, and its impact on mood and anxiety. We talk about the various delivery methods of nicotine from traditional cigarettes, which I think everybody would agree are bad, to pouches, gums, and synthetic options, ranking them from least to most harmful. The role of nicotine in physical performance, cognitive enhancement, fertility, and its interaction with other stimulants such as caffeine. We touch on the guidance for those interested in minimizing the risks while still using nicotine. And we end this podcast by looking at smoking cessation and considerations for those trying to quit smoking, which often involves using nicotine replacement. If you're a subscriber and you want to watch the full video of this podcast, you can find it on the Show Notes page. And if you're not a subscriber, you can watch the sneak peek of this video on our YouTube page. So without further delay, I hope you enjoy AMA number 70.
Peter Attia
Peter, welcome to another AMA. How are you doing?
Unknown
I'm doing really well. Thank you for having me back.
Peter Attia
I mean, we're always happy to have you whenever you would like. And again, it'd be very awkward if you weren't here. I think we do need to follow up based on one of our recent AMAs is do you still have a liquid of some form in front of you?
Unknown
I do.
Peter Attia
What kind of cup is that in?
Unknown
You know, I'm actually drinking it in a glass.
Peter Attia
Did you listen to our microplastics ama and that's why you made that change?
Unknown
Nick I have made several changes following the AMA on microplastics I believe that they are all in the spirit of 80 20. So I'm really low on the sigmoidal curve of cost and energy, with one exception. And yeah, I think I'm just taking what I think are the relatively easy steps to hopefully mitigate 80% of my exposure. And I'm going to spend no more time worrying about the last 20%, which a. I have no idea if it matters and even if it does, I don't think I could live my life and be concerned with it.
Peter Attia
That's great to hear. Two things. First is by the time this comes out, we'll most likely have a short video on what those changes were, so we'll link to that. If we don't have that video, something terribly went wrong, so we should have it. The second is, are you just so happy that you continue to join us for these AMAs, otherwise you would still be living so foolishly in your microplastic life.
Unknown
I am looking forward to the day when someone else hosts an AMA for.
Peter Attia
Me, maybe an avatar.
Unknown
That would be awesome.
Peter Attia
We could just have AI Peter, and it's just an ongoing AMA that never ends well. Today's AMA is not going to be that. It will be you live. And it is on a single topic we get asked a lot about. There's so much more use of it. We initially did an AMA on it, I think like four years ago, and at the time you didn't see as much use as you do now. And that's nicotine. So we are going to talk all things nicotine today. This is going to look at benefits, short term, long term, around everything from cognition, exercise, whatever it may be, risks of nicotine, and things that people need to be aware of. We're going to look at different ways and vehicles that people can use nicotine and what are the pros and cons. And then we're also going to end this with something that we've been asked a lot about every now and then when it comes to smoking cessation. And I think we often say a lot of people in our audience most likely are not smoking, because if you are, you're probably not opting into this deep content. But some people are. But also we hear from people where it's, hey, my parents, significant other children, friends, whatever it may be, are still doing this. How can I talk to them about quitting? So we'll cover that as well. So all that said, anything you want to say before we get rolling?
Unknown
Nope.
Peter Attia
This is a great insight that you added right there. So thank you for that. All right, to start out, can you explain just where the field of nicotine research currently stands and what's new and distinct from when we talked about this four years ago?
Unknown
One of the things that we appreciated, meaning the team and I, as we were preparing for this, was trying to appreciate how much of the research on nicotine is based on tobacco and its first application through obviously cigarettes, but then also the idea of using tobacco to extract nicotine for non smoke, but tobacco derived nicotine versus synthetic nicotine, which is honestly what a lot of people are thinking about in that context. And so I think that's important to understand that it is not always easy to tease out the impact of nicotine. And I'll foreshadow one example that we're going to talk about, which is infertility. You would think we would have legions of data that would explain the effect of nicotine on fertility, both for males and females. It turns out that if you want to talk about it through the lens of smoking, that's true. But if you want to talk about it through the lens of vaping or nicotine pouches, that's not true. And so I think that's one of the issues that I think makes this difficult to talk about with complete clarity. So anyway, I guess that's the first thing I would say. I think the second thing I would say is, and you alluded to this four years ago, we did an AMA on nicotine. Don't worry those of you that listen to that, there's very little overlap. I spent way more time talking about how nicotine worked, mechanisms of action. Today, we're probably gonna, I think, answer a lot more of the practical questions that people have. And I will also say that four years later, there's frankly more research on some of the benefits of nicotine. And to be sure, we're gonna talk about both the risks and benefits of nicotine today. So anyway, I would say that's probably a good place to start.
Peter Attia
It'd be really helpful for people double clicking on kind of one thing you hinted at there, which is for a lot of people, when they hear nicotine, there's just a negative connotation and usually it's because they associate it with tobacco, cigarettes, and so their mind initially goes to nicotine as maybe a negative, harmful thing. So do you want to maybe quickly disentangle for people the health risks of tobacco from the effects of nicotine specifically?
Unknown
Yeah, this is something I think I, maybe I didn't do a good job of this four years ago, or maybe I did. And at the end of the day, people just don't appreciate nuance. But I remember being very surprised at how a people thought that the takeaway from the podcast four years ago was we should all be using nicotine and B people were like, how can you advocate for this as a doctor? So my hope is to untangle all of that for people. Nicotine is one of many compounds found within the leaves of the tobacco plant. As such, it is in tobacco based products. But the major health concerns that are associated with tobacco, which are primarily cancer and cardiovascular disease, for reasons we can talk about another time and we're not going to talk about today, are not caused by nicotine per se, but instead they are caused by several other components of tobacco itself and tobacco smoke, such as everything from toxic metals, formaldehyde, things called polycyclic aromatic hydrocarbons. These are actually the things that are causing the harm. Now, there are byproducts of nicotine that are produced in processing tobacco and they can be carcinogenic. So that means, and this is a very important point I want to make sure, if you're trying to pay attention to the key points, this is one of them. This means that any tobacco derived nicotine product may contain carcinogens. This was actually something I did not appreciate prior. I thought that you could extract nicotine from tobacco and be completely free and clear of carcinogens. That is not the case. I want to be clear. It might be that and it likely is. In fact, it almost undoubtedly is that smoking tobacco is a much higher level of risk. But I want to make sure people understand that if your nicotine is tobacco derived as opposed to synthetic, you are still probably assuming risk. So the level of these compounds depends on the processing technique and the tobacco variety, of course. So they're found in the highest concentrations in products that actually still look like tobacco. So I think that's kind of a nice way to think about it. Everybody can imagine what a cigarette looks like. If you take tobacco chewing leaves, people chew tobacco, that's going to have a lot of the negative properties. So the more closely you are to tobacco, the worse things are. So obviously, if you're sticking it in a cigarette or a cigar or pipe, yep, you're getting plenty of it there. If you're chewing it or taking it in, snooze also a big problem. So this is why I don't think I fully appreciated this four years ago. When you take nicotine out of tobacco directly, you're still assuming some of that risk that comes in curing and fermentation of the tobacco itself.
Peter Attia
Before we move on, we should just address something because I forget sometimes people get confused by it. And even earlier this week we got an email to the website, which is, Peter, for someone who cares so much about their health, why did I see an Instagram or YouTube video of you where on your hat or your T shirt there was the Marlboro logo? Do you support cigarette smoking? So while we have people, do you just want to explain why sometimes your clothing has that and how you're not sponsored by Big Tobacco and that is not a. You should be going and smoking marble reds on the regular.
Unknown
Yeah, boy, that's okay. This is a philosophical issue, but as some people listening to this podcast know, I am an enormous fan of Formula One and that goes way back. For a long period of time and up until 2005, tobacco was a major sponsor of Formula One. In fact, the largest sponsor would have been Marlborough. And they were in the early 2000s, all over the Ferraris and in the era that is my favorite era of Formula One in the 1980s and the early 90s, they were all over the McLaren car. And so you are correct, from time to time you will see me wearing something or memorabilia that I have that is a throwback to that era of Formula one. And I believe in the original livery of those vehicles. In other words, I believe in era appropriate nods to things that we pay attention to. And so yes, if you're looking at a hat or a shirt or a car that is a replica or pays homage to something of that era, you're going to see the livery of the sponsors of the time. And that would have been Hugo Boss, Nacional, Marlboro. Anyway, there's nothing else I can say about it other than it has nothing to do with a tacit or otherwise approval of these products. I want to be unambiguously clear. I think smoking is an absolute error, arguably the single biggest unforced error you can make with respect to your health. And fortunately, Big Tobacco does not sponsor motorsport anymore and I think they're better for it.
Peter Attia
Perfect. Back to the regularly scheduled program. Nicotine. Are there any harms associated with nicotine itself based on what we just talked about then?
Unknown
Well, we're going to go into this in some detail, but I would say that clearly the biggest risk of pure nicotine, and now I'm just talking about it through the lens of synthetically acquired nicotine. So you're getting rid of all the tobacco related processing is in its addictive nature. And make no mistake about it, nicotine is highly addictive. There are some other areas where, depending on the dose, there may actually be a harm. Again, I think this is very important to understand. There are some mechanistic insights that suggest a negative impact on the endothelium, and it's certainly plausible that anything that negatively impacts the endothelium could increase the risk of cardiovascular disease. But these are not large studies. These are not studies that have been done in humans, and these are extrapolations typically from other animal models. So I guess we should probably just maybe spend a minute kind of talking about nicotine again. If people want more detail on this, I think it's covered four years ago. But nicotine activates. So nicotine is a molecule, and it activates something called the nicotinic acetylcholine receptor. Now, these receptors are not just in the brain where we most frequently talk about them, but they can actually exist throughout the body. And if you look at certain mouse models and rodent models, such as other rodents like rats, it's been demonstrated that high doses of nicotine can actually increase tumor growth and even foster metastases in addition to increasing atherosclerotic plaques. Now, that sounds pretty devastating. I just want to always point out whenever we're talking about these rodent models, there's lots of daylight, typically between what happens in that model and what happens in humans. And I think it's important to look at other ways to triangulate upon the answer. So we'll link to those studies in the show notes. But the closest thing that we could find in humans was 2024 Mendelian randomization. I know we talk about these a lot, but I always think it's worth explaining what an Mr. Is. So a Mendelian randomization says, let's look at genes in the population which we can assume are randomly assorted. That's the randomization part. And let's ask the question, will these genes be a proxy for a behavior that I want to study or something that I want to study where I can now use effectively observational tools to see if there's a difference? One example is Mendelian randomization consistently shows that LDL cholesterol is causally associated with heart disease. Why? Because LDL cholesterol is highly genetic. And you can look across a population and see different levels of ldl, even in people who are otherwise healthy, and you can examine the cardiovascular outcomes of these people, which would be the dependent variable. And that's how you could infer causality. By extension, by the way, HDL cholesterol turns out to be not causally related in the inverse. Nevertheless. So if you look at this Mendelian randomization, they wanted to look at the relationship of nicotine by itself on compromised lung function, lung cancer, copd, ch, ascvd, et cetera. Okay, I wanna be clear. I don't think this was the world's best. Mr. I think it was clever though. What did they look at? Because like, what genes would you try to parse out to understand how much tobacco someone is consuming, which is what you actually want to be able to do? So what they looked at was they looked at genes that spoke to nicotine metabolism. And so just as caffeine, we've talked about this in the past, caffeine metabolism is highly genetic. So people like me are wickedly fast at metabolizing caffeine and therefore I seem to be able to drink it later in the day without a negative impact. Someone who's a very slow metabolizer is going to feel it more. Similarly with nicotine, you have high and low levels of nicotine metabolism. And what the authors of this study postulated was people who are faster nicotine metabolizers are going to have lower levels of circulating nicotine and therefore less nicotine exposure. Now technically you could also argue that maybe someone who's a faster nicotine metabolizer would smoke more or consume more nicotine. So put that aside for the moment. But nevertheless, the authors used these genetic variants associated with nicotine metabolism to adjust for basically smoking heaviness. And again, we're not interested in the role of smoking, we're interested in the role of nicotine. Okay. Disease risk was increased with slower nicotine metabolism, but the added risk was abolished when adjusted for smoking heaviness. Because of course, if you do this, you have to adjust for smoking, indicating that the main drivers of, of the outcomes are the non nicotinic components of cigarette smoke. Let me state that. Again, this is a complicated. Mr. But it is the closest thing I think we have to looking at humans and it's looking at how much people smoked, how quickly they metabolize nicotine. Trying to do an overlay of that to appreciate the nicotine exposure and it came away basically saying that the harm of smoking is due to the tobacco and tobacco related products, not due to the nicotine. I want to be clear, this is way, way far away from what you would want to be able to say is level one evidence. If you wanted to do this in a level one fashion, you would actually have to randomize people to a whole bunch of different tobacco free nicotine products and study the outcomes of interest. Now, of course nobody's going to do that for heart outcomes like mortality, but I certainly think people could do that for softer outcomes, and my hope is that somewhere along there people do that.
Peter Attia
What do we know about potential side effects of nicotine?
Nick
Thank you for listening to today's Sneak Peek AMA episode of the Drive. If you're interested in hearing the complete version of this ama, you'll want to become a Premium member. It's extremely important to me to provide all of this content without relying on paid ads to do this. Our work is made entirely possible by our members and in return we offer exclusive member only content and benefits above and beyond what is available for free. So if you want to take your knowledge of this space to the next level, it's our goal to ensure members get back much more than the price of the subscription. Premium membership includes several benefits. First, comprehensive Podcast show notes that detail every topic, paper, person and thing that we discuss in each episode. And the word on the street is nobody's show notes rival ours. Second, monthly Ask Me Anything or AMA episodes. These episodes are comprised of detailed responses to subscriber questions typically focused on a single topic, and are designed to offer a great deal of clarity and detail on topics of special interest to our members. You'll also get access to the show notes for these episodes, of course. Third, delivery of our Premium newsletter, which is put together by our dedicated team of research analysts. This newsletter covers a wide range of topics related to longevity and provides much more detail than our free weekly newsletter. Fourth, access to our private Podcast feed that provides you with access to every episode, including AMAs sans the spiel you're listening to now and in your regular podcast feed. Fifth, the Qualys, an additional member only podcast we put together that serves as a highlight reel featuring the best excerpts from previous episodes of the Drive. This is a great way to catch up on previous episodes without having to go back and listen to each one of them. And finally, other benefits that are added along the way. If you want to learn more and access these member only benefits, you can head over to Peterattiamd.com subscribe. You can also find me on YouTube, Instagram and Twitter, all with the handle Peterattiamd. You can also leave us review on Apple Podcasts or whatever podcast player you use. This podcast is for general informational purposes only and does not constitute the practice of medicine, nursing or other professional health care services, including the giving of medical advice, no doctor patient relationship is formed. The use of this information and the materials linked to this podcast is at the user's own risk. The content on this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Users should not disregard or delay in obtaining medical advice from any medical condition they have, and they should seek the assistance of their healthcare professionals for any such conditions. Finally, I take all conflicts of interest very seriously. For all of my disclosures and the companies I invest in or Advise, please visit PeterAttiamD.com about where I keep an up to date and active list of all disclosures.
Summary of Podcast Episode #344 - AMA #70: Nicotine: Impact on Cognitive Function, Performance, and Mood, Health Risks, Delivery Modalities, and Smoking Cessation Strategies
The Peter Attia Drive Episode #344 features an in-depth Ask Me Anything (AMA) session focusing on nicotine. Hosted by Dr. Peter Attia, a Stanford/Hopkins/NIH-trained MD, this episode delves into the complexities of nicotine use, distinguishing it from tobacco, exploring its effects on health and performance, and discussing various delivery methods and cessation strategies.
Dr. Attia introduces AMA #70, highlighting the growing interest in nicotine within both scientific circles and the general public. He emphasizes the importance of distinguishing nicotine from tobacco, clarifying that nicotine is not the primary cause of the severe health risks associated with smoking.
Key Points:
The guest elaborates on the current landscape of nicotine research, noting significant advancements over the past four years.
Notable Quote:
"Four years later, there's frankly more research on some of the benefits of nicotine. And to be sure, we're gonna talk about both the risks and benefits of nicotine today."
— Unknown Speaker (05:22)
Key Points:
A critical segment where the guest clarifies the health implications of nicotine independent of tobacco use.
Notable Quotes:
"Nicotine is highly addictive."
— Unknown Speaker (12:50)
"Nicotine is one of many compounds found within the leaves of the tobacco plant... The major health concerns... are not caused by nicotine per se, but instead by several other components of tobacco itself."
— Unknown Speaker (07:29)
Key Points:
Dr. Attia addresses a misconception regarding his perceived endorsement of smoking due to his appearance in Formula One merchandise featuring historical tobacco sponsorships.
Notable Quote:
"I want to be unambiguously clear. I think smoking is an absolute error, arguably the single biggest unforced error you can make with respect to your health."
— Peter Attia (11:07)
Key Points:
The discussion delves into the specific health risks of pure nicotine, particularly synthetic nicotine, and the complexities in studying these effects.
Notable Quotes:
"Nicotine is highly addictive."
— Unknown Speaker (12:50)
"I'm not interested in the role of smoking, we're interested in the role of nicotine."
— Unknown Speaker (17:15)
Key Points:
While the transcript provided ends abruptly, the discussion emphasizes the nuanced understanding of nicotine’s role in health and performance. Dr. Attia and his guest advocate for informed use of nicotine, differentiating between its delivery methods and recognizing the importance of minimizing risks, especially for those considering cessation.
Key Takeaways:
At the episode's conclusion, Dr. Attia promotes membership benefits, including access to full AMA episodes, detailed show notes, premium newsletters, and exclusive podcasts. He clarifies that the podcast content is for informational purposes and not a substitute for professional medical advice.
Notable Quote:
"This podcast is for general informational purposes only and does not constitute the practice of medicine."
— Peter Attia (18:35)
Conclusion
This AMA session provides a comprehensive exploration of nicotine, disentangling it from the harmful effects of tobacco, discussing its potential benefits and risks, and evaluating various delivery methods. Dr. Attia and his guest offer valuable insights, emphasizing the importance of informed choices and the need for further research to fully understand nicotine's role in health and performance.